Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/2001
01/23/2001US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis
01/23/2001US6177420 Fertility control agents; side effect reduction
01/23/2001US6177402 Promoting survival of mammalian sensory neurons by contacting with leukemia inhibitory factor (lif)
01/23/2001US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
01/23/2001CA2314473A1 New b-carboline derivatives, a procedure for preparing them and the pharmaceutical compounds containing them
01/22/2001CA2746824A1 Neurotherapeutic composition and method
01/18/2001WO2001004308A1 Human lim domain proteins
01/18/2001WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins
01/18/2001WO2001004124A1 OXATHIEPINO[6,5-b]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
01/18/2001WO2001003749A1 Herb medicine composition to be contained in sanitary materials for infants
01/18/2001WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
01/18/2001WO2001003688A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds
01/18/2001WO2000066099A3 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
01/18/2001WO2000047215A3 Methods for anti-tumor therapy
01/18/2001WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON)
01/18/2001CA2379199A1 Oxathiepino[6,5-b]dihydropyridines, and related compositions and methods
01/18/2001CA2378989A1 Human lim domain proteins
01/18/2001CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs
01/17/2001EP1069114A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
01/17/2001EP1068308A1 Secreted proteins and polynucleotides encoding them
01/17/2001EP1068215A1 Azt derivatives exhibiting spermicidal and anti-viral activity
01/17/2001EP1068207A1 AMINOALKYL SUBSTITUTED 9H-PYRIDINO 2,3-b]INDOLE AND 9H-PYRIMIDINO 4,5-b]INDOLE DERIVATIVES
01/17/2001EP1068206A1 Aminoalkyl substituted pyrrolo 2,3-b]pyridine and pyrrolo 2,3-d]pyrimidine derivatives: modulators of crf1 receptors
01/17/2001EP1068205A1 Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino 2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino 4,5-b]indole derivatives: crf1 specific ligands
01/17/2001EP1068195A1 Antagonists of gonadotropin releasing hormone
01/17/2001EP1068178A1 NON-PEPTIDE GnRH AGENTS
01/17/2001EP1067956A2 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
01/17/2001EP1067931A1 Antagonists of gonadotropin releasing hormone
01/17/2001EP1067930A1 Antagonists of gonadotropin releasing hormone
01/17/2001EP1067929A1 Antagonists of gonadotropin releasing hormone
01/17/2001EP1067893A2 Human galactosyl transferases
01/17/2001CN1280620A Antigen protein and nucleic acid coding for said protein
01/17/2001CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
01/17/2001CN1279962A Chinese medicine preparation for curing mucosa ulcer
01/17/2001CN1060764C Ortho-substituted benzoylguanidine, preparation method, use as medicine or diagnostic reagent and medicine containing them
01/17/2001CN1060763C Urea-substituted benzoylguanidines, process for their preparation, and use and pharmaceutical containing them
01/17/2001CN1060679C Use of combination of angiotensin-converting enzyme inhibitor and calcium antagonist for treatment of proteinuria
01/17/2001CN1060664C Chinese drug for curing and preventing mastosis and its preparing method
01/16/2001US6174994 7TM receptor (H2CAA71)
01/16/2001US6174923 Administering ethynyl alanine amino diol compound for treating hypertension
01/16/2001US6174910 Treating pathological symptoms of vascular proliferation disorders which can be reduced or inhibited by apoptosis, by administering at.sub.1(angiotensin) receptor antagonist compound such as valsartan, irbesartan, losatran etc.
01/16/2001US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic
01/16/2001US6174884 1,5-dihydro-pyrazolo[34-D]-pyrimidinone derivatives
01/16/2001US6174714 Lyss
01/11/2001WO2001081364A1 Estra-1,3,5(10)-triene derivatives
01/11/2001WO2001002571A2 An interleukin-1 receptor antagonist and uses thereof
01/11/2001WO2001002565A2 Secreted protein zacrp4
01/11/2001WO2001002406A1 Potassium channel blocking agents
01/11/2001WO2001002387A1 N-imidazolylmethyl carboxamides as nitric oxide production inhibitors
01/11/2001WO2001002379A1 Selective npy (y5) antagonists
01/11/2001WO2001002349A1 Phenyl sulfamate derivatives
01/11/2001WO2001002006A2 Fertility impairing vaccine containing avian zona pellucida protein and method of use
01/11/2001WO2001002000A2 Method and composition for affecting reproductive systems
01/11/2001WO2001001998A2 Treatment of endometriosis with antileukoprotease
01/11/2001WO2001001932A2 Oligosaccharide aldonic acids and their topical use
01/11/2001WO2000062657A3 Improvement of t cell mediated immunity
01/11/2001WO2000061608A3 Low-molecular inhibitors of complement proteases
01/11/2001WO2000051546A3 Bupropion metabolites and methods of their synthesis and use
01/11/2001CA2380866A1 Selective npy (y5) antagonists
01/11/2001CA2378951A1 Secreted protein zacrp4
01/11/2001CA2378478A1 Fertility impairing vaccine containing avian zona pellucida protein and method of use
01/11/2001CA2378472A1 Method and composition for affecting reproductive systems
01/11/2001CA2376513A1 An interleukin-1 receptor antagonist and uses thereof
01/10/2001EP1066307A1 3',3'-n-bis-substituted macrolide lhrh antagonists
01/10/2001EP1066304A1 Macrolide lhrh antagonists
01/10/2001EP1066285A1 Antagonists of gonadotropin releasing hormone
01/10/2001EP1066257A2 Heterocylic classes of compounds for the modulating tyrosine protein kinase
01/10/2001EP1066034A1 Oxy-vanadium (iv) complexes having spermicidal activity
01/10/2001EP1066030A1 Topical hormonal composition with systemic effect
01/10/2001CN1279681A Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
01/10/2001CN1279611A Mechod for treating postmenopausal women using ultra-low-doses of estrogen
01/10/2001CN1279076A Female sterility pill
01/10/2001CN1279075A Male sterility pill
01/10/2001CN1279064A Roptazol suppository and its preparing process
01/10/2001CN1060366C Luteotropic preparation for parturient women
01/10/2001CN1060362C Prepn. process of sanitary embolus
01/09/2001US6172097 Treating psychological, eating, sexual, and nervous system disorders; anxiolytic, adrenergic blocking, and antidepressant agents; serotonin reuptake inhibitors
01/09/2001US6172080 6-azaindole compounds as antagonists of gonadotropin releasing hormone
01/09/2001US6172068 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
01/09/2001US6172060 Therapy for sexual disorders
01/09/2001US6171778 Using solution containing arabinogalactan to remove impurities and protect viability
01/04/2001WO2001000830A1 Sgip peptides
01/04/2001WO2001000829A2 Human endogenous retrovirus in breast cancer
01/04/2001WO2001000812A2 22012, a novel human carboxypeptidase
01/04/2001WO2001000811A2 17867, a novel human aminopeptidase
01/04/2001WO2001000676A1 Somatostatin agonists
01/04/2001WO2001000658A1 C-terminal modified (n-substituted)-2-indolylcarbonyldipeptides as inhibitors of the ice/ced-3 family of cysteine proteases
01/04/2001WO2001000619A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof
01/04/2001WO2001000585A1 Pyrazolidinol compounds
01/04/2001WO2001000244A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
01/04/2001WO2001000227A1 Gonadotropin releasing hormone antagonist
01/04/2001WO2001000224A1 Compositions and methods for treatment of sexual dysfunction
01/04/2001WO2001000221A2 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders
01/04/2001WO2001000047A1 Prophylactic dietary supplement based on milk
01/04/2001WO2000060082A3 Vesicle associated proteins
01/04/2001WO2000044761A3 Ketolide antibiotics
01/04/2001WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia
01/04/2001WO2000020358B1 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION
01/04/2001CA2377721A1 Sgip peptides
01/04/2001CA2377265A1 Somatostatin agonists